All In MedTech

Device Trial Radar · NCT06826599

Agreement and Precision Study of UNITY® DX and a Comparator Biometer

Last checked: Nov 19, 2026Latest source record: Aug 5, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

160

Actual

Start

Jan 18, 2025

Primary completion

Mar 30, 2025

Study completion Mar 30, 2025

Sponsor

Lead sponsor
Cylite Pty LtdNot on our public-company list
Sponsor type
Industry
First posted
Feb 14, 2025

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 22 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this study is to validate the clinical measurement performance of an investigational biometer. Subjects will undergo multiple measurements of the eye, and the agreement, repeatability, and reproducibility of the biometric measurements will be evaluated.

Conditions

  • Normal Eyes
  • Abnormal Eyes

Interventions

  • Investigational BiometerDevice

    Investigational non-contact, non-invasive ophthalmic imaging and analysis device used for visualization of ocular structures and measurement of anterior segment and biometric parameters

  • IOLMaster 700 BiometerDevice

    Commercially available non-contact instrument used to capture optical biometry measurements

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Central corneal thickness (CCT)Time frame: Day 1
  2. Lens thickness (LT)Time frame: Day 1
  3. Anterior chamber depth (regression) (ACD-R)Time frame: Day 1

1 more outcomes with a free account

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • NorthEast Eye Research Associates LLC

    Woburn, Massachusetts

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.